MiMedx Group Inc. | Ownership
Companies that own MiMedx Group Inc.
BlackRock Fund Advisors
13,735,948
12.37%
1,171,350
0%
06/30/2018
SSgA Funds Management, Inc.
8,683,306
7.82%
-2,430,625
0%
06/30/2018
The Vanguard Group, Inc.
7,526,295
6.78%
-845,259
0%
06/30/2018
Wellington Management Co. LLP
6,978,854
6.29%
-243,915
0.01%
06/30/2018
Arrowstreet Capital LP
1,671,044
1.51%
-55,511
0.02%
06/30/2018
CIBC Private Wealth Advisors, Inc.
1,485,627
1.34%
12,153
0.03%
06/30/2018
Tiedemann Wealth Management LLC
1,452,668
1.31%
250
0.47%
06/30/2018
Credit Suisse Securities (USA) LLC (Broker)
1,415,109
1.27%
-1,014,720
0.01%
06/30/2018
Northern Trust Investments, Inc.
1,384,336
1.25%
53,714
0%
06/30/2018
Norges Bank Investment Management
1,209,183
1.09%
1,209,183
0%
12/31/2017
| Address |
1775 West Oak Commons Court NE
Marietta Georgia 30062
United States
|
|
Employees
|
- |
| Website |
http://www.mimedx.com |
| Updated |
07/08/2019 |
| MiMedx Group, Inc. is a biopharmaceutical company. It engages in the design, manufacture, and marketing of regenerative biomaterials products and tissue processing services for the wound care, surgical, sports medicine, ophthalmic and dental market categories. The company's allograft product families include dHACM family with AmnioFix, EpiFix and EpiBurn brands; Amniotic Fluid family with OrthoFlo brand; Umbilical family with EpiCord and AmnioCord brands; Placental Collagen family with CollaFix and AmnioFill brands; Bone family with Physio brand; and Skin family with AlloBurn brand. |
